H. Schulz

ORCID: 0000-0003-3428-8922
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Particle physics theoretical and experimental studies
  • High-Energy Particle Collisions Research
  • Particle Detector Development and Performance
  • Quantum Chromodynamics and Particle Interactions
  • Dark Matter and Cosmic Phenomena
  • Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • CNS Lymphoma Diagnosis and Treatment
  • Computational Physics and Python Applications
  • Cosmology and Gravitation Theories
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Lung Cancer Treatments and Mutations
  • Distributed and Parallel Computing Systems
  • Glioma Diagnosis and Treatment
  • Black Holes and Theoretical Physics
  • Neutrino Physics Research
  • Psychiatric care and mental health services
  • Cancer Treatment and Pharmacology
  • Health and Medical Studies
  • Brain Metastases and Treatment
  • Advanced Data Storage Technologies
  • Mental Health Treatment and Access
  • Colorectal Cancer Treatments and Studies
  • Astrophysics and Cosmic Phenomena
  • Medical Practices and Rehabilitation

Helmholtz Zentrum München
2005-2024

Praxis für Hämatologie und Onkologie
2009-2024

German Center for Lung Research
2015-2024

Humboldt-Universität zu Berlin
2012-2023

Durham University
2016-2023

Deutsches Elektronen-Synchrotron DESY
2022

Brookhaven National Laboratory
2022

ERN GUARD-Heart
2022

University Hospital Münster
2022

Fraunhofer Institute for Material Flow and Logistics
2022

To evaluate response rate, duration, overall survival (OS), and toxicity in primary CNS lymphoma (PCNSL) after systemic intraventricular chemotherapy with deferred radiotherapy.From September 1995 to July 2001, 65 consecutive patients PCNSL (median age, 62 years) were enrolled onto a pilot phase II study evaluating without radiotherapy. A high-dose methotrexate (MTX; cycles 1, 2, 4, 5) cytarabine (ARA-C; 3 6)-based therapy (including dexamethasone, vinca-alkaloids, ifosfamide,...

10.1200/jco.2003.04.056 article EN Journal of Clinical Oncology 2003-11-04

We present a novel integrator based on normalizing flows which can be used to improve the unweighting efficiency of Monte-Carlo event generators for collider physics simulations. In contrast machine learning approaches surrogate models, our method generates correct result even if underlying neural networks are not optimally trained. exemplify new strategy using example Drell-Yan type processes at LHC, both leading and partially next-to-leading order QCD.

10.1103/physrevd.101.076002 article EN cc-by Physical review. D/Physical review. D. 2020-04-06

Sherpa is a general-purpose Monte Carlo event generator for the simulation of particle collisions in high-energy collider experiments. We summarize essential features and improvements 2.2 release series, which heavily used generation analysis interpretation LHC Run 1 2 data. highlight decade developments towards ever higher precision particle-collision events.

10.21468/scipostphys.7.3.034 article EN cc-by SciPost Physics 2019-09-18

The Forward Physics Facility (FPF) is a proposal to create cavern with the space and infrastructure support suite of far-forward experiments at Large Hadron Collider during High Luminosity era. Located along beam collision axis shielded from interaction point by least 100 m concrete rock, FPF will house that detect particles outside acceptance existing large LHC observe rare exotic processes in an extremely low-background environment. In this work, we summarize current status plans for FPF,...

10.1016/j.physrep.2022.04.004 article EN cc-by Physics Reports 2022-05-11
Margaret A. Tempero Uwe Pelzer Eileen M. O’Reilly Jordan M. Winter Do‐Youn Oh and 95 more Chung‐Pin Li Giampaolo Tortora Heung-Moon Chang Charles D. Lopez Tanios Bekaii‐Saab Andrew H. Ko Armando Santoro Joon Oh Park Marcus Smith Noel Giovanni Luca Frassineti Yan‐Shen Shan Andrew Dean Hanno Riess Eric Van Cutsem Jordan Berlin Philip Philip Malcolm J. Moore David Goldstein Josep Tabernero Mingyu Li Stefano Ferrara Yvan Le Bruchec George Zhang Brian Lu Andrew V. Biankin Michele Reni Richard A. Epstein Paul L. Vasey Jeremy Shapiro Matthew Burge Yu Jo Chua Marion Harris Nick Pavlakis Niall C. Tebbutt Gerald W. Prager Christian Dittrich Alois Lang Kathrin Philipp‐Abbrederis Richard Greil Herbert Stöger Michael Girschikofsky Thomas Kuehr Jean–Luc Van Laethem Stéphanie Laurent Neesha C. Dhani Yoo Joung Ko Scot Dowden Petr Kavan Mustapha Édouard Tehfe Eugen Kubala Milan Kohoutek Per Pfeiffer Mette Yilmaz Vibeke Parner Tapio Salminen Leena‐Maija Soveri Eija Korkeila Pia Österlund Julien Taı̈eb David Tougeron Pascal Artru François‐Xavier Caroli‐Bosc Rosine Guimbaud Anthony Turpin Thomas Walter Jean‐Baptiste Bachet Volker Kunzmann Florian Kreth Andreas De Block Marino Venerito Helmut Oettle Meinolf Karthaus Jörg Trojan Gunnar Folprecht Markus M. Lerch Frank Kullmann Marcel Reiser Volker Heinemann Marcus‐Alexander Wörns H. Schulz Benjamin Garlipp Thomas Yau Lam Stephen Chan Balázs Juhász László Landherr Tamàs Pintér G. Bodoky Zsuzsanna Kahán Ray McDermott Derek G. Power Luca Gianni Salvatore Siena Michèle Milella Alfredo Falcone Rossana Berardi

This randomized, open-label trial compared the efficacy and safety of adjuvant

10.1200/jco.22.01134 article EN cc-by-nc-nd Journal of Clinical Oncology 2022-12-15

To determine the efficacy and safety of a newly developed concomitant administration fludarabine alemtuzumab (FluCam) in patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL).A total 36 were treated this phase II study (median age, 61.47 years; mean number prior chemotherapies, 2.6; Binet stage C, n = 28). After an initial dose escalation over 3 days, 30 mg mg/m2 administered on consecutive days. Treatment was repeated after 28 days for up to six cycles. Restaging...

10.1200/jco.2005.01.9950 article EN Journal of Clinical Oncology 2005-09-07

In this article we describe Professor, a new program for tuning model parameters of Monte Carlo event generators to experimental data by parameterising the per-bin generator response parameter variations and numerically optimising parameterised behaviour. Simulated analysis is obtained using Rivet toolkit. This paper presents Professor procedure implementation, illustrated with application method tunes Pythia 6 from LEP/SLD Tevatron experiments. These are substantial improvements on existing...

10.1140/epjc/s10052-009-1196-7 article EN cc-by-nc The European Physical Journal C 2009-11-19

MET is a potential therapeutic target in lung cancer and both tyrosine kinase inhibitors monoclonal antibodies have entered clinical trials. signaling can be activated by various mechanisms, including gene amplification. In this study, we aimed to investigate amplification status adeno- squamous cell carcinomas of the lung. We propose clearly defined scores provide epidemiologic data on cancer.We evaluated prevalence increased copy numbers 693 treatment-naïve cancers FISH, clear cutoff...

10.1158/1078-0432.ccr-14-0450 article EN Clinical Cancer Research 2014-12-10

Chronic Obstructive Pulmonary Disease (COPD) influences different aspects of patient's health-related quality life (HRQL). While disease-specific HRQL instruments focus on symptoms and functional impairments, generic cover a broader view health. This study compares the EQ-5D-3 L two questionnaires (St.-George's Respiratory Questionnaire (SGRQ-C), COPD Assessment Test (CAT)) in comprehensive spectrum disease grades with particular attention comorbidities assesses discriminative abilities...

10.1186/s12890-016-0238-9 article EN cc-by BMC Pulmonary Medicine 2016-05-10

First released in 2010, the Rivet library forms an important repository for analysis code, facilitating comparisons between measurements of final state particle collisions and theoretical calculations those states. We give overview Rivet's current design implementation, its uptake preservation physics results, summarise recent developments including propagation MC systematic-uncertainty weights, heavy-ion $ep$ physics, systems detector emulation. In addition, we provide a short user guide...

10.21468/scipostphys.8.2.026 article EN cc-by SciPost Physics 2020-02-11

Event generators like play an important role in physics studies at the Large Hadron Collider (LHC). While they make accurate predictions central region, i.e., pseudorapidities <a:math xmlns:a="http://www.w3.org/1998/Math/MathML" display="inline"><a:mi>η</a:mi><a:mo>&lt;</a:mo><a:mn>5</a:mn></a:math>, a disagreement between and measurements forward region <c:math xmlns:c="http://www.w3.org/1998/Math/MathML" display="inline"><c:mi>η</c:mi><c:mo>&gt;</c:mo><c:mn>7</c:mn></c:math> has been...

10.1103/physrevd.109.016010 article EN cc-by Physical review. D/Physical review. D. 2024-01-09

Abstract Myeloproliferative neoplasms (MPN) are associated with a variety of symptoms that severely impact patients’ quality life and ability to perform daily activities. Recent studies showed differences in the perception physician- versus patient-reported symptom burden. However, directly comparing patient- physician-reported ratings lacking. Here, retrospective analysis on burden 3979 MPN patients Bioregistry German Study Group for was conducted intra-individually compare physician...

10.1038/s41375-025-02524-7 article EN cc-by Leukemia 2025-02-25

The 2011 Les Houches workshop was the first to confront LHC data. In two years since previous there have been significant advances in both soft and hard QCD, particularly areas of multi-leg NLO calculations, inclusion those calculations into parton shower Monte Carlos, tuning non-perturbative parameters Carlos. These proceedings describe theoretical that taken place, impact early data, for future development.

10.48550/arxiv.1203.6803 preprint EN other-oa arXiv (Cornell University) 2012-01-01

Due to the absence of tantalising hints for new physics during LHC's run 1, extension Higgs sector by dimension six operators will provide phenomenological standard searches non-resonant extensions Standard Model. Using all dominant and subdominant production mechanisms at LHC, we compute constraints on physics-relevant in a global correlated fit. We show how far these can be improved channels becoming accessible higher energy luminosity, both through inclusive cross sections as well highly...

10.1140/epjc/s10052-016-4227-1 article EN cc-by The European Physical Journal C 2016-07-01
Coming Soon ...